VC

Vishal Chandra

Active Director Director DIN 09025696
DIN 09025696 First appointment Jan 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2021
Shareholding value •••• Premium profile

About Vishal Chandra

Data last updated:

Vishal Chandra is a Director at Elet Pharma Private Limited (since 2021). The company operates in Chemicals. Elet Pharma Private Limited reported revenue of ₹30.8 Lakh (FY 2025).

DIN 09025696
Primary Designation Director
Industry Chemicals
First Appointment 11 Jan 2021
Oldest Company Age 5 yrs
Largest company Elet Pharma Private Limited · ₹30.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Elet Pharma Private Limited U24290PN2021PTC197605
Director11 Jan 20212021₹30.8 Lakh (FY 2025)Active

Board colleagues of Vishal Chandra

Directorship timeline

Open interactive timeline →
Elet Pharma Private Limited
Premium access

Shareholding and investment profile for Vishal Chandra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vishal Chandra

Vishal Chandra currently holds 1 directorship: Elet Pharma Private Limited (Director, since 11 Jan 2021, revenue ₹30.8 Lakh (FY 2025)).

Vishal Chandra was first appointed on 11 Jan 2021 as Director at Elet Pharma Private Limited.

The current boards of Vishal Chandra's companies include Sandeep Haldar (Elet Pharma Private Limited), Sanjeev Kumar Haldar (Elet Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available